Biofabrication Market

The biofabrication market involves the creation of 3D-printed tissue models designed to accurately simulate human biological systems. Its primary customers are pharmaceutical companies, research institutions, and biotechnology firms that utilize these models for advanced testing. Key growth drivers include the increasing volume of drugs in development pipelines, which requires more sophisticated testing methods, and a significant rise in R&D investment from both public and private sectors.

CAGR

28.3%

Compound Annual Growth Rate

Current Value

$4.32B

Estimated 2026

Projected Value

$31.7B

By 2034